This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by North, P E Articles by Brodsky, M C Search for Related Content PubMed PubMed Citation Articles by North, P E Articles by Brodsky, M C

Retinal neovascular markers in retinopathy of prematurity: aetiological implications

¹ Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA
² Department of Ophthalmology
³ Department of Otolaryngology-Head and Neck Surgery
⁴ Department of Pathology and Anatomical Sciences, University of Missouri Healthcare, Columbia, MO, USA
⁵ Department of Pediatric Ophthalmology, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

Correspondence to:
Correspondence to:
Paula E North, MD, PhD, Department of Pathology, Arkansas Children’s Hospital, 800 Marshall Street, Little Rock, AR 72202, USA;
northpaulae{at}uams.edu

ABSTRACT
Aim: (1) To determine if expression of the blood-tissue barrier associated glucose transporter GLUT1 is preserved by the neovasculature of retinopathy of prematurity (ROP), in contrast with the reported loss of GLUT1 expression in preretinal vessels of proliferative diabetic retinopathy. (2) To compare the vascular immunophenotype of ROP to juvenile haemangioma, another perinatal neovascular disorder that has recently been shown to express placental type vascular antigens, including GLUT1 and Lewis Y antigen.

Methods: A retrospective case report was carried out. Immunoreactivities for GLUT1 and Lewis Y antigen were assessed in a human eye with stage 3 ROP and compared with those in a control (paediatric) eye. The presence or absence of endothelial GLUT1 and Lewis Y immunoreactivity was determined in preretinal and intraretinal vessels.

Results: Immunoreactivity was positive for GLUT1 and negative for Lewis Y in the intraretinal and preretinal neovasculature of the ROP affected eye and in the normal retinal vessels of the control eye.

Conclusions: Retention of immunoreactivity for GLUT1 distinguishes ROP from proliferative diabetic retinopathy. Furthermore, absence of Lewis Y antigen co-expression distinguishes ROP from juvenile haemangioma, a perinatal form of GLUT1 positive neovascularisation that has recently been linked to placental vasculature.

Keywords: neovascular markers; retinopathy of prematurity

This article has been cited by other articles:

				Lucina Arch. Dis. Child., June 1, 2003; 88(6): 556 - 556. [Full Text] [PDF]